Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, přehledy
Grantová podpora
FS/10/013/28073
British Heart Foundation - United Kingdom
G0800671
Medical Research Council - United Kingdom
PG/15/103/31900
British Heart Foundation - United Kingdom
PubMed
28442312
DOI
10.1016/j.chest.2017.03.055
PII: S0012-3692(17)30735-3
Knihovny.cz E-zdroje
- Klíčová slova
- atypical hemolytic uremic syndrome, eculizumab, intensive care, organ failure, plasma exchange, thrombocytopenia, thrombotic microangiopathy,
- MeSH
- atypický hemolyticko-uremický syndrom diagnóza etiologie terapie MeSH
- diferenciální diagnóza MeSH
- dospělí MeSH
- genetické testování metody MeSH
- komplement metabolismus MeSH
- kvalita zdravotní péče normy MeSH
- lidé MeSH
- péče o pacienty v kritickém stavu normy MeSH
- protein ADAMTS13 metabolismus MeSH
- standardní péče MeSH
- výměna plazmy metody MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- ADAMTS13 protein, human MeSH Prohlížeč
- komplement MeSH
- protein ADAMTS13 MeSH
A typical hemolytic uremic syndrome (aHUS) presents similarly to thrombotic thrombocytopenic purpura (TTP) and other causes or conditions with thrombotic microangiopathy (TMA), such as disseminated intravascular coagulation or sepsis. Similarity in clinical presentation may hinder diagnosis and optimal treatment selection in the urgent setting in the ICU. However, there is currently no consensus on the diagnosis or treatment of aHUS for ICU specialists. This review aims to summarize available data on the diagnosis and treatment strategies of aHUS in the ICU to enhance the understanding of aHUS diagnosis and outcomes in patients managed in the ICU. To this end, a review of the recent literature (January 2009-March 2016) was performed to select the most relevant articles for ICU physicians. Based on the paucity of adult aHUS cases overall and within the ICU, no specific recommendations could be formally graded for the critical care setting. However, we recognize a core set of skills required by intensivists for diagnosing and managing patients with aHUS: recognizing thrombotic microangiopathies, differentiating aHUS from related conditions, recognizing involvement of other organ systems, understanding the pathophysiology of aHUS, knowing the diagnostic workup and relevant outcomes in critically ill patients with aHUS, and knowing the standard of care for patients with aHUS based on available data and guidelines. In conclusion, managing critically ill patients with aHUS requires basic skills that, in the absence of sufficient data from patients treated within the ICU, can be gleaned from an increasingly relevant literature outside the ICU. More data on critically ill patients with aHUS are needed to validate these conclusions within the ICU setting.
Fattouma Bourguiba Teaching Hospital Monastir Tunisia
Ghent University Hospital Ghent Belgium
King's College Hospital London England
Medical Intensive Care Unit Hôpital Saint Louis Paris France
Medical University of Vienna Vienna General Hospital Vienna Austria
National Research Center for Hematology Russia
University College London London England
University Hospital 1st Faculty of Medicine Charles University Prague Czech Republic
Citace poskytuje Crossref.org